Monday, December 22, 2025
ADVT 
International

Indian-origin man admits to attacking cop in Singapore

Darpan News Desk IANS, 02 Jun, 2023 01:51 PM
  • Indian-origin man admits to attacking cop in Singapore

Singapore, June 2 (IANS) An Indian-origin man in Singapore admitted to attacking a police officer in 2020 and leaving him with a bloody face, a media report said.

Nikhil M. Durgude, 25, pleaded guilty on Thursday to eight charges including one for voluntarily causing hurt to deter a public servant from his duty, The Straits Times reported.

Also charged with possessing cannabis and consuming methamphetamine, Nikhil is expected to be sentenced on June 16.

According to court documents, three officers, including Senior Staff Sergeant Chua Ming Cheng and Inspector Zheng Yiyang, went to a unit at City Suites in Balestier as part of a police operation on November 5, 2020.

They identified themselves as police to Nikhil and his accomplices, Prakash Mathivanan and Malani Naidu Prabhakar.

After a while, Prakash lunged at Staff Sergeant Chua, causing him to fall. He then hit the officer in the face and upper body, the report said.

When Inspector Zheng pointed his revolver at Prakash asking him to stop attacking, the latter grabbed his hands.

Before Chua could get up and assist Inspector Zheng, he was attacked by Nikhil, who punched and kicked him repeatedly. He fell again and Nikhil continued to assault Chua as he lay on the floor, The Straits Times reported.

"The accused did so to prevent Staff Sergeant Chua from assisting Inspector Zheng, and intending, therefore, to deter Chua from discharging his duty as such public servant," the prosecution told the court

Nikhil stopped his attack on Chua when two other officers were led into the unit after some time.

The three men were arrested and taken to the Central Police Division headquarters where the authorities detected methamphetamine in Nikhil's urine after tests.

Staff Sergeant Chua suffered a cut on the forehead and abrasions on his right elbow and left forearm, and was admitted to Singapore General Hospital for treatment.

For voluntarily causing hurt to a public servant, Nikhil could be jailed for up to seven years, caned, or fined.

MORE International ARTICLES

US recommends 'pause' for J&J vaccine

US recommends 'pause' for J&J vaccine
More than 6.8 million doses of the J&J vaccine have been administered in the U.S., the vast majority with no or mild side effects.

US recommends 'pause' for J&J vaccine

Serving Humanity At No Cost

Serving Humanity At No Cost
The purpose of this hospital is to serve humanity; Sikhs are known for this, we are doing this for years. Soon you will see, this will not be just India’s but the world’s largest kidney dialysis hospital.

Serving Humanity At No Cost

Prince Philip, Duke of Edinburgh, dead at 99

Prince Philip, Duke of Edinburgh, dead at 99
"It is with deep sorrow that Her Majesty The Queen has announced the death of her beloved husband, His Royal Highness The Prince Philip, Duke of Edinburgh," The Royal Family said on Twitter.

Prince Philip, Duke of Edinburgh, dead at 99

UK advises limiting AstraZeneca in under-30s amid clot worry

UK advises limiting AstraZeneca in under-30s amid clot worry
While the benefits of the vaccine still outweigh the risks, that assessment is “more finely balanced" among younger people who are less likely to become seriously ill with COVID-19

UK advises limiting AstraZeneca in under-30s amid clot worry

COVID vaccine found highly effective in real-world US study

COVID vaccine found highly effective in real-world US study
The two vaccines available since December — Pfizer and Moderna — were 90% effective after two doses, the Centers for Disease Control and Prevention reported Monday. In testing, the vaccines were about 95% effective in preventing COVID-19.

COVID vaccine found highly effective in real-world US study

Reputation of AstraZeneca's COVID vaccine marred by missteps

Reputation of AstraZeneca's COVID vaccine marred by missteps
In Norway, a top official warned on Monday it might not be able to resume its use of the vaccine because so many people were rejecting it.

Reputation of AstraZeneca's COVID vaccine marred by missteps